This overview examines contrast-enhanced mammography's role in breast cancer detection, highlighting cost-effectiveness and emerging technology implications for diagnosis and staging.
Contrast-enhanced mammography (CEM) is an advanced imaging technique that combines morphological and functional information to enhance breast cancer detection, similar to MRI. Using dual-energy X-rays and iodinated contrast agents, CEM highlights enhancing abnormalities and is highly sensitive in detecting malignancies, particularly in dense breasts. Its advantages include rapid image acquisition and cost-effectiveness, making it useful in screening, diagnosis, staging, and monitoring of chemotherapy response. Emerging applications of radiomics and artificial intelligence are poised to improve lesion characterization and predict molecular subtypes. While promising, CEM also has limitations, including increased radiation exposure, risks associated with contrast, potential for false results, and difficulty in widespread integration because of the limited availability of CEMguided biopsy. Overall, CEM is a valuable and cost-effective tool with increased clinical relevance. This review provides a comprehensive summary of CEM for clinical and future considerations.
No takes yet. Share an insight, caveat, or question.
Jung Min Chang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: